VANGUARD GROUP INC 13D and 13G filings for CLOVIS ONCOLOGY INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-09 3:43 pm Sale | 2021-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | VANGUARD GROUP INC | 10,115,101 7.780% | -2,179,790![]() (-17.73%) | Filing |
2021-10-12 09:29 am Purchase | 2021-09-30 | 13G | CLOVIS ONCOLOGY INC CLVSQ | VANGUARD GROUP INC | 12,294,891 10.380% | 5,907,337![]() (+92.48%) | Filing |
2021-02-10 10:46 am Purchase | 2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | VANGUARD GROUP INC | 6,387,554 7.230% | 2,169,210![]() (+51.42%) | Filing |